Home › Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly
 

Keywords :   


Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly

2015-02-11 03:12:04| Biotech - Topix.net

Bothell-based biotech Seattle Genetics , which develops cancer treatments, posted a $27 million loss on revenue of $74 million in its fourth quarter earnings today. While the company's overall sales of $74 million in the fourth quarter increased from $67 million in fourth quarter 2013, its losses also increased to $27 million from $15.7 million during the same quarter a year ago.

Tags: up stock lead loss

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
07.10Hurricane Milton Storm Surge Watch/Warning Map
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Hurricane Leslie Public Advisory Number 22
More »